These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 6257467

  • 21. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB, Morton JJ, Brown JJ, Davies DL, Fraser R, Kelly P, Leckie B, Lever AF, Robertson JI.
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [Abstract] [Full Text] [Related]

  • 22. Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.
    MacGregor GA, Markandu ND, Banks RA, Bayliss J, Roulston JE, Jones JC.
    Br Med J (Clin Res Ed); 1982 Mar 06; 284(6317):693-6. PubMed ID: 6802291
    [Abstract] [Full Text] [Related]

  • 23. Effects of single dose administration of angiotension covering enzyme inhibitor (captopril) on blood pressure, plasma renin activity and plasma aldosterone in patients with essential hypertension. A proposal for the captopril test.
    Kodama K, Morotomi Y, Kida O, Higa T, Someya N, Kondo K, Tanaka K.
    Nihon Jinzo Gakkai Shi; 1984 Sep 06; 26(9):1243-9. PubMed ID: 6392644
    [No Abstract] [Full Text] [Related]

  • 24. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril].
    Jiang M.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec 06; 19(6):342-4, 396. PubMed ID: 1668233
    [Abstract] [Full Text] [Related]

  • 25. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
    Waeber B, Brunner HR, Brunner DB, Curtet AL, Turini GA, Gavras H.
    Hypertension; 1980 Dec 06; 2(2):236-42. PubMed ID: 6247269
    [Abstract] [Full Text] [Related]

  • 26. First dose effect of the oral angiotensin converting enzyme inhibitor captopril.
    Fagard R, Amery A, Lijnen P, Staessen J.
    Arch Int Pharmacodyn Ther; 1980 Dec 06; Suppl():178-87. PubMed ID: 6251761
    [Abstract] [Full Text] [Related]

  • 27. Fluctuations in the plasma angiotensin I converting enzyme activity during long-term treatment with captopril.
    Staessen J, Fagard R, Lijnen P, Verschueren LJ, Amery A.
    Acta Cardiol; 1982 Dec 06; 37(1):1-9. PubMed ID: 6282024
    [Abstract] [Full Text] [Related]

  • 28. [Effects of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone system in normal subjects and hypertensive patients with various etiologies (author's transl)].
    Ogihara T, Maruyama A, Mikami H, Naka T, Higaki J, Kanda T, Gotoh M, Hata T, Kumahara Y.
    Nihon Jinzo Gakkai Shi; 1979 Nov 06; 21(11):1185-92. PubMed ID: 396402
    [No Abstract] [Full Text] [Related]

  • 29. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
    Sassano P, Pedrinelli R, Magagna A, Abdel-Haq B, Salvetti A.
    Am J Cardiol; 1982 Apr 21; 49(6):1574-6. PubMed ID: 6280486
    [Abstract] [Full Text] [Related]

  • 30. Dose response in captopril therapy of hypertension.
    Lijnen P, Fagard R, Staessen J, Verschueren LJ, Amery A.
    Clin Pharmacol Ther; 1980 Sep 21; 28(3):310-5. PubMed ID: 6250759
    [Abstract] [Full Text] [Related]

  • 31. [Treatment of essential hypertension with propranolol (author's transl)].
    Klumpp F, Braun B, Klaus D, Lemke R, Zehner J.
    Dtsch Med Wochenschr; 1976 Oct 08; 101(41):1482-8. PubMed ID: 183943
    [Abstract] [Full Text] [Related]

  • 32. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
    Rasmussen S, Damkjaer Nielsen M, Ibsen H, Leth A, Giese J.
    Eur J Clin Invest; 1984 Feb 08; 14(1):30-6. PubMed ID: 6321195
    [Abstract] [Full Text] [Related]

  • 33. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
    Ogihara T, Maruyama A, Hata T, Mikami H, Nakamaru M, Naka T, Ohde H, Kumahara Y.
    Clin Pharmacol Ther; 1981 Sep 08; 30(3):328-35. PubMed ID: 6268347
    [Abstract] [Full Text] [Related]

  • 34. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.
    Ideishi M, Sasaguri M, Ikeda M, Arakawa K.
    Clin Ther; 1989 Sep 08; 11(4):441-51. PubMed ID: 2550133
    [Abstract] [Full Text] [Related]

  • 35. Influence of food on acute and chronic effects of captopril in essential hypertensive patients.
    Salvetti A, Pedrinelli R, Magagna A, Abdel-Haq B, Graziadei L, Taddei S, Stornello M.
    J Cardiovasc Pharmacol; 1985 Sep 08; 7 Suppl 1():S25-9. PubMed ID: 2580172
    [Abstract] [Full Text] [Related]

  • 36. The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
    Vandenburg MJ, Holly JM, Goodwin FJ, Sharman VL, Marsh FP.
    Eur J Clin Pharmacol; 1983 Sep 08; 25(6):721-8. PubMed ID: 6319152
    [Abstract] [Full Text] [Related]

  • 37. Antihypertensive effect of the oral angiotensin I-converting enzyme inhibitor in long-term treatment of hypertensive patients.
    Mizuno K, Gotoh M, Matsui J, Fukuchi S.
    Jpn Heart J; 1981 Nov 08; 22(6):903-13. PubMed ID: 7040724
    [Abstract] [Full Text] [Related]

  • 38. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
    Hashimoto H, Hiwada K, Kokubu T.
    Jpn Circ J; 1981 Feb 08; 45(2):176-80. PubMed ID: 6262543
    [Abstract] [Full Text] [Related]

  • 39. Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.
    MacGregor GA, Markandu ND, Roulston JE, Jones JC.
    Br Med J; 1979 Nov 03; 2(6198):1106-9. PubMed ID: 229941
    [Abstract] [Full Text] [Related]

  • 40. Long-term captopril treatment in moderate to severe hypertension.
    Santucci A, Aguglia F, De Mattia G, Ficara C, Balsano F.
    Br J Clin Pharmacol; 1982 Nov 03; 14 Suppl 2(Suppl 2):77S-79S. PubMed ID: 6753908
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.